Literature DB >> 21613797

Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.

Daisuke Ozone1, Yoshio Hirano, Jiro Ueda, Tsutomu Yasukawa, Munenori Yoshida, Yuichiro Ogura.   

Abstract

PURPOSE: To investigate the feasibility and efficacy of 25-gauge vitrectomy in the treatment of proliferative diabetic retinopathy (PDR).
METHODS: All patients underwent primary 25-gauge vitrectomy for simple vitreous hemorrhage (VH), fibrovascular proliferation (FVP), or tractional retinal detachment (TD), and were followed for more than 1 month. Final visual outcomes and intraoperative and postoperative complications were evaluated.
RESULTS: 167 eyes (138 patients) were used in this study, 65 eyes (39%) with VH, 66 eyes (40%) with FVP, and 36 eyes (21%) with TD. Measured using the mean logarithm of the minimum angle of resolution (logMAR), visual acuity (VA) significantly improved (p < 0.0001). Intraoperative iatrogenic retinal breaks developed in 19 eyes (11%). Concerning postoperative complications, VH in 36 eyes (22%), retinal detachment in 2 eyes (1%), and neovascular glaucoma 12 eyes (7%) were observed. No endophthalmitis developed.
CONCLUSIONS: Twenty-five-gauge vitrectomy can successfully treat PDR. Clinical outcomes and complications are comparable to those of 20-gauge vitrectomy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21613797     DOI: 10.1159/000328407

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  10 in total

1.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

Review 2.  Surgical management of diabetic retinopathy.

Authors:  Vishali Gupta; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

Review 3.  Current concepts in diabetic retinopathy.

Authors:  Su Jeong Song; Tien Yin Wong
Journal:  Diabetes Metab J       Date:  2014-12       Impact factor: 5.376

4.  Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy.

Authors:  Erkan Celik; Ozkan Sever; Fatih Horozoglu; Ates Yanyalı
Journal:  Clin Ophthalmol       Date:  2016-05-17

5.  Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.

Authors:  Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

6.  Faster recovery after 25-gauge microincision vitrectomy surgery than after 20-gauge vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Tatsuhiko Sato; Kazuyuki Emi; Hajime Bando; Toshihide Ikeda
Journal:  Clin Ophthalmol       Date:  2012-11-21

7.  Clear Corneal Phacovitrectomy with Posterior Capsulorhexis and IOL Implantation in Management of Selective Vitreoretinal Cases.

Authors:  Ernest V Boiko; Sergey V Churashov; Alexei N Kulikov; Dmitrii S Maltsev
Journal:  J Ophthalmol       Date:  2015-10-26       Impact factor: 1.909

8.  Advantages of diabetic tractional retinal detachment repair.

Authors:  Amir Sternfeld; Ruth Axer-Siegel; Hadas Stiebel-Kalish; Dov Weinberger; Rita Ehrlich
Journal:  Clin Ophthalmol       Date:  2015-10-23

9.  Vitrectomy surgery of diabetic retinopathy complications.

Authors:  Daniel Constantin Brănişteanu; Andrei Bilha; Andreea Moraru
Journal:  Rom J Ophthalmol       Date:  2016 Jan-Mar

10.  Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy.

Authors:  Hideaki Someya; Kei Takayama; Masaru Takeuchi; Hiroshi Yokoyama; Takeshi Kimura; Masakazu Morioka; Yoshihiro Takamura; Seiji Sameshima; Tetsuo Ueda; Nahoko Ogata; Maki Tashiro; Shigehiko Kitano; Taiji Sakamoto
Journal:  J Ophthalmol       Date:  2019-12-11       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.